東京女子医科大学泌尿器科 腎泌尿器癌研究会 設立趣意書会則
東京女子医科大学泌尿器科 腎泌尿器癌研究会 The Society of Urological Disease at Tokyo Women's Medical University
■ 2022年度年報
ホーム1.はじめに2.医局構成・新入局員紹介3.東京女子医科大学腎センター泌尿器科および関連病院入院・外来・手術統計4.東京女子医科大学泌尿器科学教室 活動報告・2023年度の目標5.関連および協力施設 活動報告・2023年度の目標6.業績目録7.あとがき

6. 業績目録 >> 学術論文

学術論文



著者・共著者
発行年月 表題 掲載誌名 掲載誌名
略称
巻号頁
1海上耕平†*, 小木曽智美, 平間崇, 大木里花子, 別府寛子, 石渡亜由美, 内田啓子2022/02生体移植におけるドナー管理移植56(4):363-370
2Ishihara H, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Takagi T, Iizuka J, Ishida H, Kondo T, Tanabe K.2022Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell CarcinomaUrol Int.106(4):368-375
3吉田 一彦2022RAPN 困難症例に対する術式選択:開腹?ロボット?腎摘?
2.当院における高難度症例(high complex tumor)に対するロボット支援腎部分切除術の成績
泌尿器外科35(臨増), 791 〜 792
4NEMOTO Yuki†, ISHIHARA Hiroki*, NAKAMURA Kazutaka, TACHIBANA Hidekazu, FUKUDA Hironori, YOSHIDA Kazuhiko, KOBAYASHI Hirohito, IIZUKA Junpei, SHIMMURA Hiroaki, HASHIMOTO Yasunobu, TANABE Kazunari, KONDO Tsunenori, TAKAGI Toshio2022/01Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma.International urology and nephrologyInt Urol Nephrol54(1):47-54
5KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio2022/01Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report.Transplantation proceedingsTransplant Proc54(1):120-122
6Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Nishioki HI, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/1Association Between Anesthetic Technique and Survival After Radical Nephroureterectomy: A Propensity Score-matching Study.IN VIVO36(1):458-464
7Nemoto Y, Ishihara H, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T2022/1Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma.Int Urol Nephrol54(1):47-54
8KANZAWA Taichi†, TOKITA Daisuke*, SAIGA Kan*, YAMAKAWA Takafumi, ISHIGOOKA Hidetoshi, FUKUDA Hironori, KATSUMATA Haruki, MIYAIRI Satoshi, ISHII Rumi, HIRAI Toshihito, IMAI Toshio, OKUMI Masayoshi, TANABE Kazunari2022/02Role of fractalkine-CX3CR1 axis in acute rejection of mouse heart allografts subjected to ischemia reperfusion injuryTransplant InternationalTranspl Int36:1-10
9TACHIBANA Hidekazu†*, NEMOTO Yuki, ISHIHARA Hiroki, FUKUDA Hironori, YOSHIDA Kazuhiko, IIZUKA Junpei, HASHIMOTO Yasunobu, KONDO Tsunenori, TANABE Kazunari, TAKAGI Toshio2022/02Predictive impact of early changes in serum C-reactive protein levels in nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma.Clinical genitourinary cancerClin Genitourin Cancer20(1):e81-e88
10Tachibana H, Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Hashimoto Y, Kondo T, Tanabe K, Takagi T2022/2Predictive Impact of Early Changes in Serum C-Reactive Protein Levels in Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma.Clin Genitourin Cancer20(1):e81-e88.
11石原弘喜†, 長嶋洋治, 近藤恒徳, 高木敏男2022/03透析腎癌の遺伝子解析Urology TodayUrol Today29(1):11-17
12SHIMIZU Tomokazu†*, KATO Shinya, KIJIMA Yu, IWAMOTO Kana, HORIUCHI Toshihide, IIDA Shoichi, OMOTO Kazuya, INUI Masashi, NOZAKI Taiji, TOMA Hiroshi2022/03Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital.Transplantation proceedingsTransplant Proc54(2):282-285
13HATA Keisuke†*, ISHIDA Hideki, ISHIZUKA Kiyonobu, UNAGAMI Kohei, KANZAWA Taichi, OMOTO Kazuya, SHIMIZU Tomokazu, MIURA Kenichiro, HATTORI Motoshi, TANABE Kazunari2022/03Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg.Transplantation proceedingsTransplant Proc54(2):248-253
14T. Kondo2022/3 Is tailored systemic therapy in renal cell carcinoma realistic? Äb0Lancet Oncol23:555-7.
15Nakajima N, Miyajima A, Shinohara N, Obara W, Kondo T, Kimura G, Kume H, Fujimoto H, Sugiyama T, Nonomura N, Hongo F, Fukumori T, Takahashi M, Kanayama HO, Eto M2022/3Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.Jpn J Clin Oncol52(3):274-280
16Yoshida K, Hata K, Iizuka J, Kondo T, Ishihara H, Ishida H, Nagashima Y, Tanabe K, Takagi T2022/3Immune Checkpoint Inhibitor Combination Therapy for Renal Cell Carcinomas With Concomitant Inferior Vena Cava Thrombi.IN VIVO36(2):1030-1034
17Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Yoshida K, Takagi T, Iizuka J, Tanabe K2022/3Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus.Urol Oncol40(3):110.e11-110.e18
18巴 ひかる2022/3学会好事 第15回PPCS学術集会Urology Today29(1):52-52
19巴 ひかる2022/3特集 Female Urologyの蘊奥 積み重ねられた知恵と技術の活かし方 「企画にあたって」臨床泌尿器科76(3):173-173
20高木敏男2022/3移植患者における癌発生の疫学と特徴腎と透析92 (3): 538-542
21神澤太一†, 田邉一成2022/04定型的血管操作&吻合法腎移植・血管外科32(1):8-13
22吉田 一彦、高木敏男2022/4IO時代における転移性腎癌に対する局所治療を考える
免疫チェックポイント阻害剤時代におけるdeffered cytoreductive nephrectomy
泌尿器外科36(2), 106 〜 112
23ISHIDA Hideki†*, FURUSAWA Miyuki, UNAGAMI Kohei, OMOTO Kazuya, IIZUKA Junpei, TAKAGI Toshio2022/05Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: A retrospective cohort study at a single transplant institute in Japan.Experimental and clinical transplantation : official journal of the Middle East Society for Organ TransplantationExp Clin Transplant20(5):463-471
24OKI Rikako†, UNAGAMI Kohei*, TANEDA Sekiko, TAKAGI Toshio, ISHIDA Hideki2022/05Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.Journal of nephrologyJ Nephrol35(4):1289-1293
25近藤恒徳2022/5鏡視下手術時代におけるリンパ節郭清の意義臨床泌尿器科76(6)380-385
26Toguchi M, Kondo T, Yoshida K, Tanabe K, Takagi T.2022/5Perioperative outcomes following robot-assisted partial nephrectomy for renal cell carcinoma according to surgeon generation.BMC Surg 26;22(1):205
27Ishiyama Y, Kondo T, Ishihara H, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/5C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery.IJ Robot Surg16(3):649-654
28Wada A, Omae K, Yoshida K, Kondo T, Tanabe K, Takagi T2022/5Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre study.Jpn J Clin Oncol52(5):499-505
29Ishihara H, Nemoto Y, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T2022/5Changes in Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma from the Molecular-Targeted Therapy Era to the Immune Checkpoint Inhibitor Era.Target Oncol17(3):307-319
30Nakajima N, Miyajima A, Shinohara N, Obara W, Kondo T, Kimura G, Kume H, Fujimoto H, Sugiyama T, Nonomura N, Hongo F, Fukumori T, Takahashi M, Kanayama HO, Eto M2022/5Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.Jpn J Clin Oncol52(3):274-280
31Yudai Ishiyama 1 2, Tsunenori Kondo 3, Hiroki Ishihara 1, Kazuhiko Yoshida 2, Junpei Iizuka 2, Kazunari Tanabe 2, Toshio Takagi 22022/5C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgeryInt J Clin Oncol27(5):969-976
32TACHIBANA Hidekazu†, KONDO Tsunenori, ISHIYAMA Yudai, YOSHINO Maki, YOSHIDA Kazuhiko, IIZUKA Junpei, TANABE Kazunari, TAKAGI Toshio2022/06New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy.Journal of endourology / Endourological SocietyJ Endourol36(6):762-769
33YAGISAWA Takafumi†, TAKAGI Toshio*, YOSHIDA Kazuhiko, HATA Keisuke, IIZUKA Junpei*, MUROMIYA Yasuto, KONDO Tsunenori, TANABE Kazunari2022/06Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma.Journal of robotic surgery.16(3):649-654
34Yagisawa T, Takagi T, Yoshida K, Hata K, Iizuka J, Muromiya Y, Kondo T, Tanabe K2022/6Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma.J Robot Surg16(3):649-654
35Tachibana H, Inakawa T, Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Hashimoto Y, Tanabe K, Kondo T, Takagi T.2022/6Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment.Anticancer Res42(6):3151-3158
36Ishiyama Y, Kondo T, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/6Thrombus-first or "thrombus-last" approach for surgical management of renal cell carcinoma with inferior vena cava thrombus.Int J Urol29(6):559-565
37Tachibana H, Omae K, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Tanabe K, Kondo T, Takagi T2022/06Validation of a Predictive Model for New Baseline Renal Function After Radical Nephrectomy or Robot-Assisted Partial Nephrectomy in Japanese Patients.J Endourol36(6):745-751
38Tachibana H, Kondo T, Ishiyama Y, Yoshino M, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/6New Longitudinal Component of the RENAL Nephrometry Score for Predicting the Operative Complexity in Transperitoneal Robot-Assisted Partial Nephrectomy.J Endourol36(6):762-769
39巴 ひかる2022/6プラタナス~私のカルテから~「右足でボールが受けられません」週間 日本医事新報(5120):3-3
40巴 ひかる2022/6Ⅲ.高齢者良性泌尿器疾患の病態と治療 尿失禁・骨盤臓器脱日本臨牀 特集 高齢者の泌尿器疾患update-病態に基づく診断・治療上の問題点-80(6):965-971
41巴 ひかる2022/6特集 下部尿路機能障害(排尿障害)へのアプローチ 「間質性膀胱炎」診断と治療110(6):771-776
42長嶋洋治†*、池口歩美、稲垣茉里子、高木敏男2022/07腎細胞癌の病理診断Rinsho byori. The Japanese journal of clinical pathologyRinsho Byori70(6):537-542
43KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, KANO Kana, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio2022/07A case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus.Transplantation proceedingsTransplant Proc54(6):1561-1563
44KIJIMA Yu†*, SHIMIZU Tomokazu, SEKIDO Eri, KATO Shinya, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio2022/07Allogeneic kidney transplantation after COVID-19: A case report.Transplantation proceedingsTransplant Proc54(6):1551-1553
45KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio2022/07Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report.Transplantation proceedingsTransplant Proc54(6):1547-1550
46ISHIHARA Hiroki†*, NEMOTO Yuki, TACHIBANA Hidekazu, FUKUDA Hironori, YOSHIDA Kazuhiko, KOBAYASHI Hirohito, IIZUKA Junpei, HASHIMOTO Yasunobu, TAKAGI Toshio, ISHIDA Hideki, KONDO Tsunenori, TANABE Kazunari2022/07Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.Japanese journal of clinical oncologyJpn J Clin Oncol52(7):785-790
47Nishimura K, Ishihara H, Kondo T, Toguchi M, Fukuda H, Tachibana H, Toki D, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/7Assessment of Feasibility of Robot-assisted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy.IN VIVO36(4):1801-1806
48Nemoto Y, Ishihara H, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T2022/7Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria.Target Oncol17(4):475-482
49Yoshida K, Kondo T, Iizuka J, Fukuda H, Ishihara H, Kobayashi H, Okumi M, Ishida H, Tanabe K, Takagi T2022/7Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study.Int J Clin Oncol27(10):1624-1631
50Ishihara H, Nemoto Y, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Hashimoto Y, Takagi T, Ishida H, Kondo T, Tanabe K2022/7Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.Jpn J Clin Oncol52(7):785-790
51Yuki Nemoto· Hiroki Ishihara · Kazutaka Nakamura · Hidekazu Tachibana · Hironori Fukuda · Kazuhiko Yoshida · Hirohito Kobayashi · Junpei Iizuka · Hiroaki Shimmura · Yasunobu Hashimoto · Kazunari Tanabe · Tsunenori Kondo · Toshio Takagi 2022/7Efficacy and Safety of Immunotherapy‐Based Combinations as First‐Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria Targeted Oncology 17, 475–482 (2022).
52Hiroki Ishihara 1, Yuki Nemoto 2, Hidekazu Tachibana 1, Hironori Fukuda 3, Kazuhiko Yoshida 3, Hirohito Kobayashi 1, Junpei Iizuka 3, Yasunobu Hashimoto 2, Toshio Takagi 3, Hideki Ishida 3, Tsunenori Kondo 1, Kazunari Tanabe 32022/7Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-upJpn J Clin Oncol52(7):777-782
53Ishiyama Y2022/7Editorial Comment to Impact of early postoperative creatinine increase on mid-term renal function after cystectomy Int J Urol
54服部元史*, 石塚喜世伸, 三浦健一郎, 白井陽子†, 安藤太郎, 田邉一成, 神澤太一, 石田英樹2022/08二次生体腎移植により生活の質の改善を得られた口顔指症候群の1例日本小児腎不全学会雑誌42:163-165
55神澤太一†, 田邉一成2022/08腎動脈瘤に対する外科的治療経験腎移植・血管外科33(1):21-26
56Ishihara H, Ishiyama Y, Nemoto Y, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T2022/8Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.Clin Genitourin CancerS1558-7673(22)00169-0
57吉田 一彦2022/8各領域における分子標的薬の役割(4)臨床 3:泌尿器科領域における分子標的薬の役割 ―腎細胞癌の薬物療法を中心に― 東女医大誌 92(4) 119-125, 2022.8
58KANETSUNA Yukiko†, TANABE Kazunari, HATTORI Motoshi, NITTA Kosaku, MORIYAMA Takahito, HORITA Shigeru, YAMAGUCHI Yutaka2022/09Central fibrous areas: changes in glomerular vascular pole lesions associated with age and disease.International urology and nephrologyInt Urol Nephrol54(9):2263-2273
59Hiroki Ishihara 1, Tsunenori Kondo 1, Toshio Takagi 22022/9Editorial Comment from Dr Ishihara et al. to Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high-volume centerInt J Urol29(9):993-994
60巴 ひかる2022/9【講演Ⅱ】頻尿と尿失禁の治療公益財団法人 日本国際医学協会誌(513):3-4
61高木敏男2022/9ロボット支援腹腔鏡下根治的腎摘除術ー後腹膜アプローチ泌尿器外科35 (9): 968-971
62古澤美由紀†, 石田英樹, 神澤太一, 八木澤隆史, 石井晃太, 海上耕平, 尾本和也, 飯塚淳平, 田邉一成, 高木敏男2022/10腎移植患者におけるSARS-CoV-2 mRNAワクチン接種後の抗体反応についての研究(第1報)移植57(2):141-151
63Ishiyama Y, Kondo T, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/10Efficacy and feasibility of robot-assisted partial nephrectomy for octogenarians: comparison with younger counterparts.J Robot Surg16(5):1165-1173
64Yoshino M, Ishihara H, Nemoto Y, Nakamura K, Nishimura K, Tachibana H, Fukuda H, Toki D, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T2022/10Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.Jpn J Clin Oncol52(10):1208-1214
65Ishihara H, Fukuda H, Yoshida K, Hashimoto Y, Kondo T, Takagi T2022/11Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma.Int J UrolEpub ahead of print
66Yoshida K, Kobari Y, Iizuka J, Kondo T, Ishida H, Tanabe K, Takagi T2022/11Robot-assisted laparoscopic versus open partial nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.Int J Urol29(11):1349-1355
67Takagi T, Yoshida K, Fukuda H, Kobari Y, Iizuka J.2022/11/29Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application "My Intuitives".Int J Urol2022 Nov;29(11): 1381-1385.
68尾本和也†*, 海上耕平, 神澤太一, 乾政志, 田邉一成, 高木敏男, 石田英樹2022/12腎移植後腎性貧血に対するHIF-PH阻害薬の使用経験日本臨床腎移植学会雑誌日臨腎移植会誌10(2):201-208
69海上耕平†*, 尾本和也, 大木里花子, 高木敏男, 石田英樹2022/12腎移植後患者とSARS-CoV-2ワクチン日本臨床腎移植学会雑誌日臨腎移植会誌10(2):148-154
70笹野まゆ†*, 石塚敏, 小林悠梨, 安尾美年子, 三浦ひとみ, 岩藤和広, 江川裕人, 石田英樹2022/12ABO血液型不適合生体腎移植における抗血液型IgG抗体検出法の開発日本臨床腎移植学会雑誌日臨腎移植会誌10(2):274-282
71矢代麻友佳†,関敦子*,高木敏男,鬼塚裕美,増井憲太,山本智子,長嶋洋治2022/12ロボット支援腎部分切除術を施行された腎類上皮性血管筋脂肪腫の3例診断病理in press
72近藤恒徳2022/12ロボット腎部分切除における高難度腫瘍に対する腎機能を意識した切除について日本ミニマム創泌尿器内視鏡外科学会雑誌14:71-77
73Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Iizuka J, Tanabe K, Takagi T2022/12Impact of Warm Ischemia on Acute Kidney Injury After Robotic Partial Nephrectomy Stratified by Baseline Kidney Function.J EndourolEpub ahead of print
74Toshihito Hirai, Po-Yu Lin, Teresa L Ramos, Federico Simonetta, Leon L Su, Lora K Picton, Jeanette Baker, Juliane K Lohmeyer, K Christopher Garcia, Robert S Negrin. 2022/12IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor. American Journal of TransplantationAm J Transplant22(12):3061-3068. (PMID 36031344)
75Teresa Lopes Ramos, Sara Bolivar-Wagers, Sujeong Jin, Govindarajan Thangavelu, Federico Simonetta, Po-Yu Lin, Toshihito Hirai, Asim Saha, Brent H Koehn, Leon L Su, Lora K Picton, Jeanette Baker, Juliane K Lohmeyer, Megan J Riddle, Cindy Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, John E Wagner, K Christopher Garcia, Robert S Negrin, Bruce R Blazar.2022/12Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo.BloodBlood23;blood.2022018440. (PMID 36564052)
76Juliane K Lohmeyer, Toshihito Hirai, Mustafa Turkoz, Stephane Buhler, Teresa Lopes Ramos, Natalie Köhler, Jeanette Baker, Astrid Melotti, Ingrid Wagner, Amandine Pradier, Sisi Wang, Xuhuai Ji, Simone Becattini, Jean Villard,
Doron Merkler, Yves Chalandon, Robert S Negrin, Federico Simonetta.
2022/12Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD. Blood Blood27;blood.2022017982. (PMID 36574344)
77根本侑樹、萩原鮎夢、坂本鉄志、柴山隆宏、佐藤英章、山崎早苗、橋本恭伸2022当院における限局性前立腺癌に対する術式別周術期成績の比較検討埼玉県医学会雑誌57(1): 333-339

[ 前のページへ戻る ] [ ページトップへ戻る ]

Copyright (C) The Society of Urological Disease at TWMU All Rights Reserved.